2 results
Approved WMOCompleted
To study whether hyqvia is as effective, safe and tolerable (or more tolerable) as IVIg.
Approved WMOCompleted
Primary objective:To evaluate the objective response rate (ORR) of AZD1775 in combination with gemcitabine, carboplatin, paclitaxel,or PLD in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancerSecondary…